Activation of Nrf2 by microcystin-LR provides advantages for liver cancer cell growth.

Microcystin-LR (MC-LR) is a potent heptapeptide hepatotoxin at high doses, but its underlying mechanism of promoting liver cell proliferation at low doses is unclear. The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) is key in mediating the protective antioxidant response against various environmental toxicants, but emerging data suggest that constitutive activation of Nrf2 contributes to a malignant phenotype. The purpose of this study was to characterize the interactions and effects of Nrf2 activation on cell proliferation induced by MC-LR treatment. Treatment of HepG2 and Hep3B cells with MC-LR resulted in significant increases in Nrf2-ARE binding activities in the nuclear fractions and upregulation of its downstream genes HO-1 and NQO1. A possible mechanism may be that MC-LR binds to the cytosolic regulator protein Keap1 to liberate Nrf2. Nrf2 knockdown inhibited MC-LR-induced cell proliferation and cell cycle progression. Together, these results indicate that MC-LR-induced upregulation of Nrf2 in cancer cells promotes liver cancer cell growth and suggest a positive role of Nrf2 in tumorigenesis.

[1]  Jun Chen,et al.  Activation of Nrf2 by cadmium and its role in protection against cadmium-induced apoptosis in rat kidney cells. , 2009, Toxicology and applied pharmacology.

[2]  Lirong Song,et al.  Detection of microcystins in environmental samples using surface plasmon resonance biosensor. , 2009, Talanta.

[3]  N. Kikuchi,et al.  Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer , 2009, Clinical Cancer Research.

[4]  P. Wong,et al.  Dual roles of Nrf2 in cancer. , 2008, Pharmacological research.

[5]  Weimin Chen,et al.  Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. , 2008, Carcinogenesis.

[6]  S. Hirohashi,et al.  Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. , 2008, Cancer research.

[7]  G. Shaw,et al.  Interaction of the cyanobacterial toxin cylindrospermopsin with the eukaryotic protein synthesis system. , 2008, Toxicon : official journal of the International Society on Toxinology.

[8]  X. He,et al.  Protection against Chromium (VI)‐induced oxidative stress and apoptosis by Nrf2. recruiting Nrf2 into the nucleus and disrupting the nuclear Nrf2/Keap1 association by toxic metal , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[9]  C. Klaassen,et al.  Role of NAD(P)H:quinone oxidoreductase 1 in clofibrate-mediated hepatoprotection from acetaminophen. , 2007, Toxicology.

[10]  J. Herman,et al.  Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer , 2006, PLoS medicine.

[11]  X. He,et al.  Arsenic Induces NAD(P)H-quinone Oxidoreductase I by Disrupting the Nrf2·Keap1·Cul3 Complex and Recruiting Nrf2·Maf to the Antioxidant Response Element Enhancer* , 2006, Journal of Biological Chemistry.

[12]  Tsutomu Ohta,et al.  Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. , 2006, Molecular cell.

[13]  Jiankun Cui,et al.  Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Donna D. Zhang.  Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway , 2006, Drug metabolism reviews.

[15]  Masayuki Yamamoto,et al.  Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. , 2006, Advances in enzyme regulation.

[16]  Yongliang Zhu,et al.  Transformation of immortalized colorectal crypt cells by microcystin involving constitutive activation of Akt and MAPK cascade. , 2005, Carcinogenesis.

[17]  Jiang Li,et al.  Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  N. Gan,et al.  An ELISA-like time-resolved fluorescence immunoassay for microcystin detection. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[19]  M. Gehringer.  Microcystin‐LR and okadaic acid‐induced cellular effects: a dualistic response , 2004, FEBS letters.

[20]  Y. Kan,et al.  Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduc , 2004, The Biochemical journal.

[21]  Mark Hannink,et al.  Distinct Cysteine Residues in Keap1 Are Required for Keap1-Dependent Ubiquitination of Nrf2 and for Stabilization of Nrf2 by Chemopreventive Agents and Oxidative Stress , 2003, Molecular and Cellular Biology.

[22]  H. Schulman,et al.  Ca2+/Calmodulin-dependent Protein Kinase II Is Required for Microcystin-induced Apoptosis* , 2002, The Journal of Biological Chemistry.

[23]  C. Ong,et al.  Pivotal role of mitochondrial Ca(2+) in microcystin-induced mitochondrial permeability transition in rat hepatocytes. , 2001, Biochemical and biophysical research communications.

[24]  J. Patočka,et al.  The toxins of Cyanobacteria. , 2001, Acta medica.

[25]  C. Ong,et al.  Critical Role of Reactive Oxygen Species and Mitochondrial Permeability Transition in Microcystin‐Induced Rapid Apoptosis in Rat Hepatocytes , 2000, Hepatology.

[26]  R. Foresti,et al.  Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. , 2000, The Biochemical journal.

[27]  R. Mulcahy,et al.  Regulation of γ-Glutamylcysteine Synthetase Subunit Gene Expression by the Transcription Factor Nrf2* , 1999, The Journal of Biological Chemistry.

[28]  F. Tashiro,et al.  Enhancement of glutathione S-transferase placental-form positive liver cell foci development by microcystin-LR in aflatoxin B1-initiated rats. , 1999, Carcinogenesis.

[29]  J. D. Engel,et al.  Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. , 1999, Genes & development.

[30]  P. Workman,et al.  DT-diaphorase and cancer chemotherapy. , 1992, Biochemical pharmacology.

[31]  J. Zwiller,et al.  Characterization of microcystin-LR, a potent inhibitor of type 1 and type 2A protein phosphatases. , 1990, The Journal of biological chemistry.